Conceiving post-breast cancer: Pausing endocrine therapy is safe, study confirms
The trial is the first to address the lack of safety data around temporary interruptions to endocrine therapy in premenopausal women
Young women with previous breast cancer can safely pause endocrine therapy for up to two years to attempt pregnancy, according to a landmark international study.
Results from the POSITIVE trial suggest temporary interruption of endocrine therapy following stage I-III hormone receptor-positive breast cancer had no negative effects among those who wished to conceive.
